▶ 調査レポート

世界の非侵襲的がん診断市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Non-invasive Cancer Diagnosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の非侵襲的がん診断市場 2021:企業別、地域別、種類・用途別 / Global Non-invasive Cancer Diagnosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12513資料のイメージです。• レポートコード:GIR-107A12513
• 出版社/出版日:GlobalInfoResearch / 2021年7月
• レポート形態:英文、PDF、80ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、非侵襲的がん診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非侵襲的がん診断の種類別市場規模(臨床化学、免疫化学/イムノアッセイ、分子診断、その他)、用途別市場規模(血液がん、固形がん、乳がん、肺がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・非侵襲的がん診断の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Gen-Probe Inc.、A&G Pharmaceutical、Affymetrix Inc.、Digene Corporation、Quest Diagnostics Inc.、BioView Inc.、LabCorp、AVIVA Biosciences Corporation、Precision Therapeutics
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:臨床化学、免疫化学/イムノアッセイ、分子診断、その他
・用途別分析2016年-2026年:血液がん、固形がん、乳がん、肺がん、その他
・非侵襲的がん診断の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・非侵襲的がん診断のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・非侵襲的がん診断のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・非侵襲的がん診断の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・非侵襲的がん診断の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Non-invasive Cancer Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Non-invasive Cancer Diagnosis size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Non-invasive Cancer Diagnosis market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Non-invasive Cancer Diagnosis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others

Market segment by Application, can be divided into
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others

Market segment by players, this report covers
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-invasive Cancer Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-invasive Cancer Diagnosis, with revenue, gross margin and global market share of Non-invasive Cancer Diagnosis from 2019 to 2021.
Chapter 3, the Non-invasive Cancer Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-invasive Cancer Diagnosis market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-invasive Cancer Diagnosis research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Non-invasive Cancer Diagnosis
1.2 Classification of Non-invasive Cancer Diagnosis by Type
1.2.1 Overview: Global Non-invasive Cancer Diagnosis Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Type in 2020
1.2.3 Clinical Chemistry
1.2.4 Immunochemistry/Immunoassay
1.2.5 Molecular Diagnostics
1.2.6 Others
1.3 Global Non-invasive Cancer Diagnosis Market by Application
1.3.1 Overview: Global Non-invasive Cancer Diagnosis Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Blood Cancer
1.3.3 Solid Tumors
1.3.4 Breast Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Global Non-invasive Cancer Diagnosis Market Size & Forecast
1.5 Global Non-invasive Cancer Diagnosis Market Size and Forecast by Region
1.5.1 Global Non-invasive Cancer Diagnosis Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Non-invasive Cancer Diagnosis Market Size by Region, (2016-2021)
1.5.3 North America Non-invasive Cancer Diagnosis Market Size and Prospect (2016-2026)
1.5.4 Europe Non-invasive Cancer Diagnosis Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Non-invasive Cancer Diagnosis Market Size and Prospect (2016-2026)
1.5.6 South America Non-invasive Cancer Diagnosis Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Non-invasive Cancer Diagnosis Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-invasive Cancer Diagnosis Market Drivers
1.6.2 Non-invasive Cancer Diagnosis Market Restraints
1.6.3 Non-invasive Cancer Diagnosis Trends Analysis
2 Company Profiles
2.1 Gen-Probe Inc.
2.1.1 Gen-Probe Inc. Details
2.1.2 Gen-Probe Inc. Major Business
2.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Product and Solutions
2.1.4 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Gen-Probe Inc. Recent Developments and Future Plans
2.2 A&G Pharmaceutical
2.2.1 A&G Pharmaceutical Details
2.2.2 A&G Pharmaceutical Major Business
2.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Product and Solutions
2.2.4 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 A&G Pharmaceutical Recent Developments and Future Plans
2.3 Affymetrix Inc.
2.3.1 Affymetrix Inc. Details
2.3.2 Affymetrix Inc. Major Business
2.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Product and Solutions
2.3.4 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Affymetrix Inc. Recent Developments and Future Plans
2.4 Digene Corporation
2.4.1 Digene Corporation Details
2.4.2 Digene Corporation Major Business
2.4.3 Digene Corporation Non-invasive Cancer Diagnosis Product and Solutions
2.4.4 Digene Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Digene Corporation Recent Developments and Future Plans
2.5 Quest Diagnostics Inc.
2.5.1 Quest Diagnostics Inc. Details
2.5.2 Quest Diagnostics Inc. Major Business
2.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product and Solutions
2.5.4 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.6 BioView Inc.
2.6.1 BioView Inc. Details
2.6.2 BioView Inc. Major Business
2.6.3 BioView Inc. Non-invasive Cancer Diagnosis Product and Solutions
2.6.4 BioView Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BioView Inc. Recent Developments and Future Plans
2.7 LabCorp
2.7.1 LabCorp Details
2.7.2 LabCorp Major Business
2.7.3 LabCorp Non-invasive Cancer Diagnosis Product and Solutions
2.7.4 LabCorp Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 LabCorp Recent Developments and Future Plans
2.8 AVIVA Biosciences Corporation
2.8.1 AVIVA Biosciences Corporation Details
2.8.2 AVIVA Biosciences Corporation Major Business
2.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product and Solutions
2.8.4 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AVIVA Biosciences Corporation Recent Developments and Future Plans
2.9 Precision Therapeutics
2.9.1 Precision Therapeutics Details
2.9.2 Precision Therapeutics Major Business
2.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Product and Solutions
2.9.4 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Precision Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-invasive Cancer Diagnosis Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-invasive Cancer Diagnosis Players Market Share
3.2.2 Top 10 Non-invasive Cancer Diagnosis Players Market Share
3.2.3 Market Competition Trend
3.3 Non-invasive Cancer Diagnosis Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-invasive Cancer Diagnosis Revenue and Market Share by Type (2016-2021)
4.2 Global Non-invasive Cancer Diagnosis Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Non-invasive Cancer Diagnosis Revenue Market Share by Application (2016-2021)
5.2 Non-invasive Cancer Diagnosis Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Non-invasive Cancer Diagnosis Revenue by Type (2016-2026)
6.2 North America Non-invasive Cancer Diagnosis Revenue by Application (2016-2026)
6.3 North America Non-invasive Cancer Diagnosis Market Size by Country
6.3.1 North America Non-invasive Cancer Diagnosis Revenue by Country (2016-2026)
6.3.2 United States Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
6.3.3 Canada Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
6.3.4 Mexico Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-invasive Cancer Diagnosis Revenue by Type (2016-2026)
7.2 Europe Non-invasive Cancer Diagnosis Revenue by Application (2016-2026)
7.3 Europe Non-invasive Cancer Diagnosis Market Size by Country
7.3.1 Europe Non-invasive Cancer Diagnosis Revenue by Country (2016-2026)
7.3.2 Germany Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
7.3.3 France Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
7.3.5 Russia Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
7.3.6 Italy Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Type (2016-2026)
8.2 Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Application (2016-2026)
8.3 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region
8.3.1 Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Region (2016-2026)
8.3.2 China Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8.3.3 Japan Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8.3.4 South Korea Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8.3.5 India Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
8.3.7 Australia Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Non-invasive Cancer Diagnosis Revenue by Type (2016-2026)
9.2 South America Non-invasive Cancer Diagnosis Revenue by Application (2016-2026)
9.3 South America Non-invasive Cancer Diagnosis Market Size by Country
9.3.1 South America Non-invasive Cancer Diagnosis Revenue by Country (2016-2026)
9.3.2 Brazil Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
9.3.3 Argentina Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Type (2016-2026)
10.2 Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Application (2016-2026)
10.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country
10.3.1 Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Country (2016-2026)
10.3.2 Turkey Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
10.3.4 UAE Non-invasive Cancer Diagnosis Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Non-invasive Cancer Diagnosis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Non-invasive Cancer Diagnosis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Non-invasive Cancer Diagnosis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Non-invasive Cancer Diagnosis Revenue (USD Million) by Region (2016-2021)
Table 5. Global Non-invasive Cancer Diagnosis Revenue Market Share by Region (2021-2026)
Table 6. Gen-Probe Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Gen-Probe Inc. Major Business
Table 8. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product and Solutions
Table 9. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. A&G Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 11. A&G Pharmaceutical Major Business
Table 12. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product and Solutions
Table 13. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Affymetrix Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Affymetrix Inc. Major Business
Table 16. Affymetrix Inc. Non-invasive Cancer Diagnosis Product and Solutions
Table 17. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Digene Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Digene Corporation Major Business
Table 20. Digene Corporation Non-invasive Cancer Diagnosis Product and Solutions
Table 21. Digene Corporation Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Quest Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Quest Diagnostics Inc. Major Business
Table 24. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product and Solutions
Table 25. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BioView Inc. Corporate Information, Head Office, and Major Competitors
Table 27. BioView Inc. Major Business
Table 28. BioView Inc. Non-invasive Cancer Diagnosis Product and Solutions
Table 29. BioView Inc. Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. LabCorp Corporate Information, Head Office, and Major Competitors
Table 31. LabCorp Major Business
Table 32. LabCorp Non-invasive Cancer Diagnosis Product and Solutions
Table 33. LabCorp Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AVIVA Biosciences Corporation Corporate Information, Head Office, and Major Competitors
Table 35. AVIVA Biosciences Corporation Major Business
Table 36. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product and Solutions
Table 37. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Precision Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Precision Therapeutics Major Business
Table 40. Precision Therapeutics Non-invasive Cancer Diagnosis Product and Solutions
Table 41. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Non-invasive Cancer Diagnosis Revenue (USD Million) by Players (2019-2021)
Table 43. Global Non-invasive Cancer Diagnosis Revenue Share by Players (2019-2021)
Table 44. Breakdown of Non-invasive Cancer Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Non-invasive Cancer Diagnosis Players Head Office, Products and Services Provided
Table 46. Non-invasive Cancer Diagnosis Mergers & Acquisitions in the Past Five Years
Table 47. Non-invasive Cancer Diagnosis New Entrants and Expansion Plans
Table 48. Global Non-invasive Cancer Diagnosis Revenue (USD Million) by Type (2016-2021)
Table 49. Global Non-invasive Cancer Diagnosis Revenue Share by Type (2016-2021)
Table 50. Global Non-invasive Cancer Diagnosis Revenue Forecast by Type (2021-2026)
Table 51. Global Non-invasive Cancer Diagnosis Revenue by Application (2016-2021)
Table 52. Global Non-invasive Cancer Diagnosis Revenue Forecast by Application (2021-2026)
Table 53. North America Non-invasive Cancer Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Non-invasive Cancer Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Non-invasive Cancer Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Non-invasive Cancer Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Non-invasive Cancer Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Non-invasive Cancer Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Non-invasive Cancer Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Non-invasive Cancer Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Non-invasive Cancer Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Non-invasive Cancer Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Non-invasive Cancer Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Non-invasive Cancer Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Non-invasive Cancer Diagnosis Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Non-invasive Cancer Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Non-invasive Cancer Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Non-invasive Cancer Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Non-invasive Cancer Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Non-invasive Cancer Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Non-invasive Cancer Diagnosis Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Non-invasive Cancer Diagnosis Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Non-invasive Cancer Diagnosis Picture
Figure 2. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type in 2020
Figure 3. Clinical Chemistry
Figure 4. Immunochemistry/Immunoassay
Figure 5. Molecular Diagnostics
Figure 6. Others
Figure 7. Non-invasive Cancer Diagnosis Revenue Market Share by Application in 2020
Figure 8. Blood Cancer Picture
Figure 9. Solid Tumors Picture
Figure 10. Breast Cancer Picture
Figure 11. Lung Cancer Picture
Figure 12. Others Picture
Figure 13. Global Non-invasive Cancer Diagnosis Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Non-invasive Cancer Diagnosis Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Non-invasive Cancer Diagnosis Revenue Market Share by Region (2016-2026)
Figure 16. Global Non-invasive Cancer Diagnosis Revenue Market Share by Region in 2020
Figure 17. North America Non-invasive Cancer Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Non-invasive Cancer Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Non-invasive Cancer Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Non-invasive Cancer Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Non-invasive Cancer Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Non-invasive Cancer Diagnosis Market Drivers
Figure 23. Non-invasive Cancer Diagnosis Market Restraints
Figure 24. Non-invasive Cancer Diagnosis Market Trends
Figure 25. Gen-Probe Inc. Recent Developments and Future Plans
Figure 26. A&G Pharmaceutical Recent Developments and Future Plans
Figure 27. Affymetrix Inc. Recent Developments and Future Plans
Figure 28. Digene Corporation Recent Developments and Future Plans
Figure 29. Quest Diagnostics Inc. Recent Developments and Future Plans
Figure 30. BioView Inc. Recent Developments and Future Plans
Figure 31. LabCorp Recent Developments and Future Plans
Figure 32. AVIVA Biosciences Corporation Recent Developments and Future Plans
Figure 33. Precision Therapeutics Recent Developments and Future Plans
Figure 34. Global Non-invasive Cancer Diagnosis Revenue Share by Players in 2020
Figure 35. Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Non-invasive Cancer Diagnosis Revenue Market Share in 2020
Figure 37. Global Top 10 Players Non-invasive Cancer Diagnosis Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Non-invasive Cancer Diagnosis Revenue Share by Type in 2020
Figure 40. Global Non-invasive Cancer Diagnosis Market Share Forecast by Type (2021-2026)
Figure 41. Global Non-invasive Cancer Diagnosis Revenue Share by Application in 2020
Figure 42. Global Non-invasive Cancer Diagnosis Market Share Forecast by Application (2021-2026)
Figure 43. North America Non-invasive Cancer Diagnosis Sales Market Share by Type (2016-2026)
Figure 44. North America Non-invasive Cancer Diagnosis Sales Market Share by Application (2016-2026)
Figure 45. North America Non-invasive Cancer Diagnosis Revenue Market Share by Country (2016-2026)
Figure 46. United States Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Non-invasive Cancer Diagnosis Sales Market Share by Type (2016-2026)
Figure 50. Europe Non-invasive Cancer Diagnosis Sales Market Share by Application (2016-2026)
Figure 51. Europe Non-invasive Cancer Diagnosis Revenue Market Share by Country (2016-2026)
Figure 52. Germany Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Non-invasive Cancer Diagnosis Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Non-invasive Cancer Diagnosis Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Non-invasive Cancer Diagnosis Revenue Market Share by Region (2016-2026)
Figure 60. China Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Non-invasive Cancer Diagnosis Sales Market Share by Type (2016-2026)
Figure 67. South America Non-invasive Cancer Diagnosis Sales Market Share by Application (2016-2026)
Figure 68. South America Non-invasive Cancer Diagnosis Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Non-invasive Cancer Diagnosis Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Non-invasive Cancer Diagnosis Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Non-invasive Cancer Diagnosis Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Non-invasive Cancer Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source